Nationwide population-level real-world evidence of long-term mortality, liver and non-liver benefits of DAA therapy in patients with chronic hepatitis treated with direct-acting antivirals
Nationwide population-level real-world evidence of long-term mortality, liver and non-liver benefits of DAA therapy in patients with chronic hepatitis treated with direct-acting antivirals
复制标题
全国人口水平的真实世界证据，表明直接作用抗病毒药物治疗的慢性肝炎患者 DAA 治疗的长期死亡率、肝脏和非肝脏益处
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Eiichi Ogawa
中科院分区：
文献类型：
--
作者：
Hiroyuki Yamamoto;Anna Iijima;Kumiko Kawamura;Yasuo Matsuzawa;Masahiro Suzuki;Yoshichika Arakawa;Eiichi Ogawa
